Marta A. Crispens

7.7k total citations
62 papers, 1.8k citations indexed

About

Marta A. Crispens is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Marta A. Crispens has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Reproductive Medicine, 18 papers in Obstetrics and Gynecology and 15 papers in Oncology. Recurrent topics in Marta A. Crispens's work include Ovarian cancer diagnosis and treatment (30 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Endometriosis Research and Treatment (7 papers). Marta A. Crispens is often cited by papers focused on Ovarian cancer diagnosis and treatment (30 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Endometriosis Research and Treatment (7 papers). Marta A. Crispens collaborates with scholars based in United States, Canada and Brazil. Marta A. Crispens's co-authors include Janet E. Price, Corazon D. Bucana, Hiroki Kuniyasu, Junya Yoneda, Isaiah J. Fidler, Oluwole Fadare, Dineo Khabele, Andrew J. Wilson, Alicia Beeghly‐Fadiel and Howard W. Jones and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Marta A. Crispens

60 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta A. Crispens United States 25 723 568 498 447 296 62 1.8k
Laura Zanotti Italy 27 732 1.0× 546 1.0× 527 1.1× 369 0.8× 352 1.2× 76 1.9k
Maria Luisa Gasparri Italy 27 866 1.2× 651 1.1× 452 0.9× 928 2.1× 462 1.6× 100 2.3k
Gustavo C. Rodriguez United States 29 1.2k 1.6× 781 1.4× 733 1.5× 607 1.4× 498 1.7× 78 2.7k
Toshio Hirakawa Japan 25 893 1.2× 573 1.0× 339 0.7× 524 1.2× 135 0.5× 55 1.8k
Salvatore Lopez Italy 25 619 0.9× 369 0.6× 551 1.1× 606 1.4× 183 0.6× 89 1.6k
A.G.J. van der Zee Netherlands 24 434 0.6× 593 1.0× 528 1.1× 318 0.7× 251 0.8× 53 1.6k
Fabian Trillsch Germany 25 712 1.0× 802 1.4× 577 1.2× 456 1.0× 568 1.9× 128 2.1k
Jacob Korach Israel 24 886 1.2× 311 0.5× 567 1.1× 565 1.3× 109 0.4× 107 1.6k
Carmela Pisano Italy 26 862 1.2× 532 0.9× 706 1.4× 447 1.0× 292 1.0× 95 1.9k
Yasuyuki Hirashima Japan 26 362 0.5× 557 1.0× 542 1.1× 455 1.0× 406 1.4× 81 1.8k

Countries citing papers authored by Marta A. Crispens

Since Specialization
Citations

This map shows the geographic impact of Marta A. Crispens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta A. Crispens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta A. Crispens more than expected).

Fields of papers citing papers by Marta A. Crispens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta A. Crispens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta A. Crispens. The network helps show where Marta A. Crispens may publish in the future.

Co-authorship network of co-authors of Marta A. Crispens

This figure shows the co-authorship network connecting the top 25 collaborators of Marta A. Crispens. A scholar is included among the top collaborators of Marta A. Crispens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta A. Crispens. Marta A. Crispens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hufnagel, Demetra, Dineo Khabele, Fiona E. Yull, et al.. (2021). Increasing Area Deprivation Index negatively impacts ovarian cancer survival. Cancer Epidemiology. 74. 102013–102013. 32 indexed citations
2.
Hufnagel, Demetra, Andrew J. Wilson, Jamie A. Saxon, et al.. (2020). Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis. Biomarker Research. 8(1). 45–45. 7 indexed citations
3.
Zuckerwise, Lisa C., et al.. (2019). Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. American Journal of Obstetrics and Gynecology. 222(2). 179.e1–179.e9. 59 indexed citations
5.
Wilson, Andrew J., et al.. (2016). Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib. Gynecologic Oncology. 143(1). 143–151. 34 indexed citations
7.
Desouki, Mohamed Mokhtar, et al.. (2014). Differential Vimentin Expression in Ovarian and Uterine Corpus Endometrioid Adenocarcinomas. International Journal of Gynecological Pathology. 33(3). 274–281. 16 indexed citations
8.
Desouki, Mohamed Mokhtar, Dineo Khabele, Marta A. Crispens, & Oluwole Fadare. (2014). Ovarian Mucinous Tumor With Malignant Mural Nodules. International Journal of Gynecological Pathology. 34(1). 19–24. 17 indexed citations
9.
Wilson, Andrew J., Joseph T. Roland, James C. Slaughter, et al.. (2013). TR3 Modulates Platinum Resistance in Ovarian Cancer. Cancer Research. 73(15). 4758–4769. 36 indexed citations
10.
Gold, Michael A., William E. Brady, Heather A. Lankes, et al.. (2012). A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology. 125(3). 635–639. 41 indexed citations
12.
Khabele, Dineo, et al.. (2012). An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma.. PubMed. 5(1). 37–45. 13 indexed citations
13.
Fleischer, Arthur C., Andrej Lyshchik, Howard W. Jones, et al.. (2009). Diagnostic Parameters to Differentiate Benign From Malignant Ovarian Masses With Contrast-Enhanced Transvaginal Sonography. Journal of Ultrasound in Medicine. 28(10). 1273–1280. 34 indexed citations
14.
Fleischer, Arthur C., Andrej Lyshchik, Howard W. Jones, et al.. (2008). Contrast-Enhanced Transvaginal Sonography of Benign Versus Malignant Ovarian Masses. Journal of Ultrasound in Medicine. 27(7). 1011–1018. 44 indexed citations
16.
Milam, Michael R., Stephen J. Schultenover, Marta A. Crispens, & Lynn P. Parker. (2004). Retroperitoneal Fibrosis Secondary to Actinomycosis With No Intrauterine Device. Obstetrics and Gynecology. 104(5). 1134–1136. 12 indexed citations
17.
Crispens, Marta A.. (2003). Borderline ovarian tumours: a review of the recent literature. Current Opinion in Obstetrics & Gynecology. 15(1). 39–43. 24 indexed citations
18.
Crispens, Marta A.. (2002). Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstetrics and Gynecology. 99(1). 3–10. 117 indexed citations
19.
Crispens, Marta A., et al.. (1996). Complications of midtrimester pregnancy termination: The effect of prior cesarean delivery. American Journal of Obstetrics and Gynecology. 175(4). 889–892. 58 indexed citations
20.
Watts, Raymond G., Marta A. Crispens, & Thomas H. Howard. (1991). A quantitative study of the role of F‐actin in producing neutrophil shape. Cell Motility and the Cytoskeleton. 19(3). 159–168. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026